The move toward using the Digital Application Dataset Integration (DADI) project for the initial implementation of IDMP-based regulatory data submissions offers both opportunities and challenges for pharmaceutical organizations.
Renato Rjavec
Advertisement
Renato Rjavec is director of product management at Amplexor Life Sciences.
Articles by Renato Rjavec
Advertisement
Latest Updated Articles
What DADI Means for the Pharmaceutical IndustryPublished: May 2nd 2022 | Updated:
Advertisement
Advertisement
